In Ethiopia, smear microscopy was a routine TB diagnostic tool for decades. Thus, an advanced diagnostic tool is required to detect and treat TB in Ethiopia. Įarly case detection and treatment of TB cases were among the key strategies of the National TB and Leprosy Control Program (NTLCP). In 2015, the prevalence of multiple drug-resistant TB (MDR-TB) reached 2.7% in new TB cases and 14.0% in retreated TB cases in Ethiopia. It is also the leading cause of mortality in Ethiopia with a TB incidence of 163 cases per 100,000 population reported in 2016.

Tuberculosis (TB) remains a considerable public health threat in Africa. Incremental cost-effectiveness ratio MDR-TB, The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.Ĭompeting interests: The authors have declared that no competing interests exist. AH was supported by a Bill & Melinda Gates Foundation Grant (OPP1162384).

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: All relevant data are within the manuscript and its Supporting Information files.įunding: AK was supported by an Addis Ababa University School of Public Health Grant. Received: JAccepted: OctoPublished: October 25, 2021Ĭopyright: © 2021 Kaso, Hailu. PLoS ONE 16(10):Įditor: Frederick Quinn, The University of Georgia, UNITED STATES Citation: Kaso AW, Hailu A (2021) Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.

Cost of expert gps